These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2687059)

  • 1. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.
    Lampeter EF; Signore A; Gale EA; Pozzilli P
    Diabetologia; 1989 Oct; 32(10):703-8. PubMed ID: 2687059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice.
    Kolb H
    Diabetes Metab Rev; 1987 Jul; 3(3):751-78. PubMed ID: 2956075
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
    Strandell E; Eizirik DL; Sandler S
    J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diabetic syndrome of the 'BB' Wistar rat: possible relevance to type 1 (insulin-dependent) diabetes in man.
    Marliss EB; Nakhooda AF; Poussier P; Sima AA
    Diabetologia; 1982 Apr; 22(4):225-32. PubMed ID: 7047269
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha and insulin-dependent diabetes mellitus.
    Mueller C; Imboden MA; Hess MW; Laissue JA; Carnaud CC
    Res Immunol; 1993 Jun; 144(5):331-5. PubMed ID: 8278654
    [No Abstract]   [Full Text] [Related]  

  • 9. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
    Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
    Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
    You S; Chatenoud L
    Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity and beta cell regeneration in mouse and human type 1 diabetes: the peace is not enough.
    Ablamunits V; Sherry NA; Kushner JA; Herold KC
    Ann N Y Acad Sci; 2007 Apr; 1103():19-32. PubMed ID: 17376841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages.
    Hutchings P; Rosen H; O'Reilly L; Simpson E; Gordon S; Cooke A
    Nature; 1990 Dec; 348(6302):639-42. PubMed ID: 2250718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
    Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
    Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of vasostatin-1-specific CD8(+) T cells in non-obese diabetic mice that contribute to diabetes pathogenesis.
    Nikoopour E; Krougly O; Lee-Chan E; Haeryfar SM; Singh B
    Clin Exp Immunol; 2016 Sep; 185(3):292-300. PubMed ID: 27185276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
    Buschard K
    Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
    Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
    Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The non-obese diabetic (NOD) mouse.
    Leiter EH; Prochazka M; Coleman DL
    Am J Pathol; 1987 Aug; 128(2):380-3. PubMed ID: 3303953
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes mellitus and cellular immunity].
    Paknys G; Kondrotas AJ; Kevelaitis E
    Medicina (Kaunas); 2006; 42(1):1-10. PubMed ID: 16467607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.